|
CA2445826C
(en)
|
2001-05-02 |
2014-03-25 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
|
US8043602B2
(en)
|
2002-02-07 |
2011-10-25 |
Endocyte, Inc. |
Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
|
|
US8043603B2
(en)
|
2002-02-07 |
2011-10-25 |
Endocyte, Inc. |
Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
|
|
WO2004020462A1
(ja)
|
2002-08-27 |
2004-03-11 |
Fujii, Nobutaka |
Ｃｘｃｒ４拮抗薬およびその用途
|
|
WO2005103721A1
(en)
*
|
2004-04-20 |
2005-11-03 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 4 (cxcr4)
|
|
AU2006203826A1
(en)
|
2005-01-07 |
2006-07-13 |
Emory University |
CXCR4 antagonists for the treatment of HIV infection
|
|
WO2006091112A1
(en)
*
|
2005-02-22 |
2006-08-31 |
Genesis Reasearch And Development Corporation Limited |
Compositions for the delivery of rna interference molecules and methods for their use
|
|
US8569280B2
(en)
|
2005-04-25 |
2013-10-29 |
Immune Disease Institute |
Methods for the treatment of multiple myeloma
|
|
US7825088B2
(en)
*
|
2005-04-25 |
2010-11-02 |
The Cbr Institute For Biomedical Research, Inc. |
Methods for the treatment of multiple myeloma
|
|
DE102005023170A1
(de)
*
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
|
US9034814B2
(en)
|
2005-05-25 |
2015-05-19 |
Hadasit Medical Research Services And Development Ltd. |
CXCR4 antagonists for wound healing and re-epithelialization
|
|
US20070009434A1
(en)
|
2005-07-05 |
2007-01-11 |
Low Philip S |
Imaging and therapeutic method using monocytes
|
|
CA2619828A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Genzyme Corporation |
Methods to enhance chemotherapy
|
|
US8795633B2
(en)
|
2005-09-23 |
2014-08-05 |
Purdue Research Foundation |
Multiphoton in vivo flow cytometry method and device
|
|
WO2007058322A1
(ja)
|
2005-11-18 |
2007-05-24 |
Ono Pharmaceutical Co., Ltd. |
塩基性基を含有する化合物およびその用途
|
|
EP2397148A3
(en)
*
|
2006-02-02 |
2012-04-25 |
Allergan, Inc. |
Compositions and methods for the treatment of ophthalmic disease
|
|
WO2007096662A2
(en)
*
|
2006-02-27 |
2007-08-30 |
Technische Universität München |
Cancer imaging and treatment
|
|
TW200808328A
(en)
*
|
2006-06-02 |
2008-02-16 |
Alcon Mfg Ltd |
RNAi-mediated inhibition of stromal cell-derived factor 1-related targets for treatment of neovascularization-related conditions
|
|
EP2041067A4
(en)
|
2006-07-11 |
2009-11-25 |
Univ Emory |
CXER4 ANTAGONISTS WITH DIAZINE AND TRIAZINE STRUCTURES FOR THE TREATMENT OF MEDICAL PROBLEMS
|
|
JP2010509570A
(ja)
|
2006-11-03 |
2010-03-25 |
パーデュー・リサーチ・ファウンデーション |
エクスビボフローサイトメトリーの方法および装置
|
|
CA2673719C
(en)
|
2006-12-21 |
2018-07-24 |
Biokine Therapeutics Ltd. |
T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery
|
|
US8586595B2
(en)
|
2007-02-07 |
2013-11-19 |
Purdue Research Foundation |
Positron emission tomography imaging method
|
|
CA2688308A1
(en)
|
2007-05-25 |
2008-12-04 |
Purdue Research Foundation |
Method of imaging localized infections
|
|
EP2197469A2
(en)
*
|
2007-09-11 |
2010-06-23 |
Mondobiotech Laboratories AG |
Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection
|
|
AU2009228034A1
(en)
|
2008-03-28 |
2009-10-01 |
Altiris Therapeutics |
Chemokine receptor modulators
|
|
AU2009311645C1
(en)
|
2008-11-04 |
2014-10-02 |
Acer Therapeutics Inc. |
CXCR4 receptor compounds
|
|
US9427456B2
(en)
|
2009-06-14 |
2016-08-30 |
Biokine Therapeutics Ltd. |
Peptide therapy for increasing platelet levels
|
|
WO2011094389A2
(en)
*
|
2010-01-27 |
2011-08-04 |
Emory University |
Cxcr4 antagonists for imaging of cancer and inflammatory disorders
|
|
US9155795B2
(en)
|
2010-02-26 |
2015-10-13 |
Anchor Therapeutics, Inc. |
CXCR4 receptor compounds
|
|
US20130310442A1
(en)
*
|
2010-09-09 |
2013-11-21 |
Noxxon Pharma Ag |
SDF-1 Binding Nucleic Acids and the use Thereof in Cancer Treatment
|
|
EP2663320A1
(en)
|
2011-01-10 |
2013-11-20 |
Biokine Therapeutics Ltd. |
Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
|
|
EP2476441A1
(en)
|
2011-01-13 |
2012-07-18 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
|
|
CA2852160A1
(en)
|
2011-10-28 |
2013-05-02 |
Galderma Research & Development |
New leukocyte infiltrate markers for rosacea and uses thereof
|
|
US9439942B2
(en)
|
2012-04-24 |
2016-09-13 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
|
EP2978439B1
(en)
|
2013-03-24 |
2017-08-16 |
Biokine Therapeutics Ltd. |
A combination of a cxcr4 antagonist and cytarabine for use in treating myeloid leukemia
|
|
CA2928315C
(en)
|
2013-10-31 |
2023-03-21 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
|
CA2937992A1
(en)
|
2014-02-03 |
2015-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of eliminating stem cells
|
|
KR101700946B1
(ko)
*
|
2014-11-11 |
2017-02-02 |
연세대학교 산학협력단 |
Ｃｘｃｒ４ 길항제를 포함하는 피부 색소침착의 예방 또는 개선용 조성물
|
|
US11311552B2
(en)
*
|
2015-04-02 |
2022-04-26 |
Proximagen, Llc |
Therapies for cancer
|
|
IL274572B2
(en)
|
2015-07-16 |
2024-01-01 |
Biolinerx Ltd |
Compositions and methods for treating cancer
|
|
WO2017011517A1
(en)
|
2015-07-16 |
2017-01-19 |
Emory University |
Bis-amines, compositions, and uses related to cxcr4 inhibition
|
|
US10434195B2
(en)
|
2015-08-03 |
2019-10-08 |
Emory University |
Methylsulfonamide derivatives and uses related thereto
|
|
CN109310733A
(zh)
|
2016-02-23 |
2019-02-05 |
百欧林纳克斯有限公司 |
治疗急性骨髓性白血病的方法
|
|
EP3856225A1
(en)
|
2018-09-25 |
2021-08-04 |
BioLineRx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
|
CN110590744B
(zh)
*
|
2019-07-03 |
2021-11-02 |
河南省人民医院 |
一种靶向趋化因子受体cxcr4的小分子类pet显像剂
|